A COMPARATIVE-ANALYSIS OF THE PHARMACEUTICAL MARKET IN 4 EUROPEAN COUNTRIES

[1] Andersson F., Methodological aspects of international drug price comparisons, PharmacoEconomics, 4, (1993)

[2] Garattini L., Metodologie per la determinazione dei prezzi dei farmaci nei principali paesi europei, (1993)

[3] Taylor D., Maynard A., Medicines, The NHS and Europe: balancing the public’s interests, (1990)

[4] Jensen A., Reference prices for pharmaceuticals, Recent experiences with a new instrument in health politics, (1991)

[5] Selke G.W., DeAuswirkungen der Arzneimittelfestbetrage, Arzneiverordnungs report, (1992)

[6] Schneider M., Dennerlein R-H, Kose A., Et al., Health care systems in the EC members states, Health Policy, 20, pp. 1-252, (1992)

[7] Garattini S., Garattini L., 1993 pharmaceutical prescriptions in four European countries, Lancet, 342, (1993)

[8] Sen A., The standard of living, Lecture I: concepts and critiques, (1985)

[9] Sen A., The standard of living, Lecture II: lives and capabilities, (1985)

[1] Andersson F., Methodological aspects of international drug price comparisons, PharmacoEconomics, 4, (1993)

[2] Garattini L., Metodologie per la determinazione dei prezzi dei farmaci nei principali paesi europei, (1993)

[3] Taylor D., Maynard A., Medicines, The NHS and Europe: balancing the public’s interests, (1990)

[4] Jensen A., Reference prices for pharmaceuticals, Recent experiences with a new instrument in health politics, (1991)

[5] Selke G.W., DeAuswirkungen der Arzneimittelfestbetrage, Arzneiverordnungs report, (1992)

[6] Schneider M., Dennerlein R-H, Kose A., Et al., Health care systems in the EC members states, Health Policy, 20, pp. 1-252, (1992)

[7] Garattini S., Garattini L., 1993 pharmaceutical prescriptions in four European countries, Lancet, 342, (1993)

[8] Sen A., The standard of living, Lecture I: concepts and critiques, (1985)

[9] Sen A., The standard of living, Lecture II: lives and capabilities, (1985)